Literature DB >> 4041089

Sequence of the DNA-binding protein of a human subgroup E adenovirus (type 4): comparisons with subgroup A (type 12), subgroup B (type 7), and subgroup C (type 5).

G R Kitchingman.   

Abstract

The nucleotide sequence of the gene for the single-stranded DNA-binding protein of adenovirus type 4 (Ad4) has been determined. The gene codes for a protein of 512 amino acids. Comparison of the amino acid sequence with those previously determined for Ad5, Ad12, and Ad7 allowed identification of regions that are conserved between the four serotypes. These include stretches of 9, 9, and 12 amino acids in the carboxy-terminal domain of the protein; these sequences are similar to those identified in the single-stranded DNA-binding proteins of procaryotes as being important for interaction of the protein with single-stranded DNA. A conserved region of four amino acids in the amino-terminal domain is identical in sequence to a region of the SV40 large T antigen that has recently been implicated in the nuclear localization of the protein. Other conserved amino acids that may be important for the three-dimensional structure of the protein have also been identified. The overall homology between the DBPs of the four serotypes is 17.2% in the amino-terminal domain, 47.8% in the carboxy-terminal domain. Two-way comparisons between the DBPs of the four serotypes indicates that the DBP of Ad4 is most closely related to that of Ad7.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041089     DOI: 10.1016/0042-6822(85)90055-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3.

Authors:  P S Reddy; N Idamakanti; A N Zakhartchouk; M K Baxi; J B Lee; C Pyne; L A Babiuk; S K Tikoo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  Splice site consensus sequences are preferentially accessible to nucleases in isolated adenovirus RNA.

Authors:  S H Munroe; R S Duthie
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

3.  The small nuclear ribonucleoprotein SS-B/La binds RNA with a conserved protease-resistant domain of 28 kilodaltons.

Authors:  E K Chan; E M Tan
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  Stimulation of the adenovirus major late promoter in vitro by transcription factor USF is enhanced by the adenovirus DNA binding protein.

Authors:  D C Zijderveld; F d'Adda di Fagagna; M Giacca; H T Timmers; P C van der Vliet
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Functional analysis of the adenovirus type 5 DNA-binding protein: site-directed mutants which are defective for adeno-associated virus helper activity.

Authors:  C O Quinn; G R Kitchingman
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Mutations that affect phosphorylation of the adenovirus DNA-binding protein alter its ability to enhance its own synthesis.

Authors:  N Morin; C Delsert; D F Klessig
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  CD and DNA binding studies of a proline repeat-containing segment of the replication arrest protein Tus.

Authors:  M L Nedved; P A Gottlieb; G R Moe
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

8.  Conserved region 3 of the adenovirus type 5 DNA-binding protein is important for interaction with single-stranded DNA.

Authors:  G A Neale; G R Kitchingman
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  The adenovirus DNA binding protein enhances intermolecular DNA renaturation but inhibits intramolecular DNA renaturation.

Authors:  D C Zijderveld; M H Stuiver; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

10.  Functional changes in temperature-sensitive mutants of the adenovirus single-stranded DNA-binding protein are accompanied by structural alterations.

Authors:  M Tsuji; G R Kitchingman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.